Pour plus de facilité, laissez cette case cochée. Sur les appareils partagés, nous vous conseillons de vous déconnecter d'Euroquity à la fin de votre utilisation
Email

Vous allez recevoir un email pour créer un nouveau mot de passe

Localisation

Choisissez votre pays

et votre langue

Bonjour ,

Bienvenue sur votre profil personnel. Votre carte de visite professionnelle présente votre activité principale. Elle sera visible sur EuroQuity.

% complété

%

medal 1
Ce profil est validé par 1 label.

Company

EpiLAB

EpiLAB_logo
24
EQ SCORE

L'EQ Score indique l'activité et l'attractivité de l'entreprise sur la plateforme : complétude du profil, actualités, likes, follows, appartenance à un ou plusieurs labels ou communautés, nombre de membres de son réseau, etc.

Paris, Île-de-France, France

Send a message

Anglais

EpiLAB

Anglais

Tuberculosis is a devastating pandemic, the disease claimes 1,5 million victims each year. According to the WHO, in 2020, 10 million people fell ill with tuberculosis among which 3 million are not diagnosed . These cases are extremely contagious and lead to 10 million infections the following year. These 3 million patients are untreated and half of them die from the disease. 
The main reason for this...

See more

Tuberculosis is a devastating pandemic, the disease claimes 1,5 million victims each year. According to the WHO, in 2020, 10 million people fell ill with tuberculosis among which 3 million are not diagnosed . These cases are extremely contagious and lead to 10 million infections the following year. These 3 million patients are untreated and half of them die from the disease. 
The main reason for this under-diagnosis is the lack of appropriate testing in developing countries, where 90% of cases are located : every available tests require medical infrastructure and qualifications, while those countries are lacking of both.

EpiLAB is addressing this problem by developing the first portable and easy to use tuberculosis diagnosis test. To do so, EpiLAB leverages a patented tuberculosis detection method using specific enzymatic reactions coupled with electrochemical detection. This technology is low cost, operates on battery and could be deployed by individuals without any medicine qualification. Essentially, our goal is to elaborate a pristine screening kit for tuberculosis.

EpiLAB is supported by French and world renowned tuberculosis expert. The WHO has also confirmed the great interest for EpiLAB test, and many NGOs and National Program to fight TB have sent letters of interest to EpiLAB.

EpiLAB is closing a 500k€ round to complete its R&D and will be looking for 5M€ next year to start industrial production.

 

Team member(s)

Your request has been sent
Join this organization
Your request has been sent

Team member(s)

Our network

Your request has been sent
Join this network
Your message has been sent

Certifications

SATT SAYENS
5 Entities

Communities

SATT
SATTs are Societies By Simplified Actions created by several public research centers as part of the "Investments for the Future" Program (french PIA); within the commercialization department.
302 Members
Les Deeptech
Les Deeptech, c’est la communauté qui rassemble les startups deeptech françaises et les investisseurs désirant développer des relations business avec elles.
344 Members